CAS 209984-57-6 appears in our catalog under these names: LY-411575/ 97.03% (existing batch purity), LY–411575, LY 411575, LY-411575, >95.0%(HPLC)(qNMR), LY411575, 98%, 98%. Offered by: TargetMol, GLPBio, Biosynth, TCI, Chemat. Available pack sizes: 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso), 1000mg.
LY-411575 is a dibenzoazepine that is 5,7-dihydro-6H-dibenzo[b,d]azepin-6-one which is substituted at the 7 pro-S position by the C-terminal carboxamide nitrogen of N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-L-alaninamide. It is a potent, cell permeable and selective gamma-secretase inhibitor. It has been tested as a possible treatment for Alzheimer's disease and shows promise for its potential to counteract severe hearing loss. It has a role as an EC 3.4.23.46 (memapsin 2) inhibitor. It is a lactam, a secondary alcohol, a difluorobenzene and a dibenzoazepine.
Source: ChEBI
| Molecular formula | C26H23F2N3O4 |
|---|---|
| Molecular weight | 479.5 g/mol |
| IUPAC name | (2S)-2-[[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino]-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide |
| InChIKey | ULSSJYNJIZWPSB-CVRXJBIPSA-N |
| SMILES | C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C4=CC(=CC(=C4)F)F)O |
Computed by PubChem (NCBI)